Justices Appear Skeptical of Investor-Harm Requirement in Sripetch SEC Disgorgement Case

Why It Matters

A ruling that mandates proof of investor harm could limit the SEC’s ability to seek disgorgement as an equitable remedy, potentially turning it into a civil penalty and reshaping enforcement strategy. This shift would affect settlement dynamics and could increase litigation costs for both the SEC and regulated entities.

Key Takeaways

• Supreme Court to decide if SEC must prove investor harm for disgorgement
• Decision could force SEC to identify harmed investors and quantify losses
• If deemed a civil penalty, SEC may need jury trials for disgorgement
• July 2026 ruling may reshape SEC’s leverage in settlement negotiations

Pulse Analysis

The dispute over SEC disgorgement traces back to the 2020 Liu decision, where the Court framed disgorgement as an equitable remedy "for the benefit of investors" but left open whether proof of investor loss was required. Congress responded with §21(d)(7) in 2021, stripping the benefit‑of‑investors language and granting the Commission broader authority to seek disgorgement. This statutory amendment created a split among the circuits, with some still applying the traditional unjust‑enrichment model and others demanding a harm showing. The Supreme Court’s review in Sripetch therefore serves as a pivotal test of how the post‑Liu framework aligns with the newer statutory language.

If the justices require the SEC to prove pecuniary harm, the agency’s enforcement arsenal could be significantly narrowed. Disgorgement would shift toward a civil‑penalty classification, obligating the SEC to prove specific investor losses and potentially subjecting each disgorgement action to a Seventh Amendment jury trial. Such a procedural hurdle would raise the cost and complexity of securities enforcement, likely prompting the Commission to rely more on settlements that avoid full trials or to pursue alternative remedies like civil penalties under §21(d)(3).

The market impact extends beyond litigation strategy. Companies facing SEC investigations may gain leverage in negotiations, as the threat of a costly jury trial diminishes the Commission’s leverage. Investors, meanwhile, could see slower restitution of ill‑gotten gains if the SEC must first trace and quantify individual losses. Practitioners should monitor the July 2026 decision closely, reassess risk models for potential disgorgement exposure, and consider proactive compliance measures that document investor harm to mitigate future enforcement risk.